91桃色

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open 91桃色

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Lipid lowering therapy (statins) suppresses oxidative stress, apoptotic signaling, and neuroinflammation in experimental stroke model induced by cerebral ischemia/reperfusion in diabetic rats

3rd International Conference on Clinical Pharmacy

Hagar H and Maha Arafa

King Saud University, Saudi Arabia

Posters-Accepted Abstracts: Clin Pharmacol Biopharm

DOI:

Abstract
Background: Diabetes is recognized as a major risk factor in the development of cerebrovascular disease along with other factors as hypertension, dyslipidemia and obesity. Stroke occurs 2 to 4 times more frequently in adults with diabetes than in those who are healthy. Statins represent promising classes of agents for prevention or treatment of stroke. Materials & Methods: The rats were divided into five groups of ten rats each. (I) Normal control group; (II) Diabetic rats (diabetes was induced by a single intraperitoneal injection of streptozotocin 55 mg/kg, in citrate buffer, pH 4.5); (III) Ischemia/reperfusion diabetic group were subjected to cerebral ischemia (I) for 1 hr/24 h reperfusion (R), and (IV) and (V) groups were treated with simvastatin (20 mg/kg), and fluvastatin (10 mg/kg) for 10 days, respectively before undergoing ischemia/reperfusion. Results: Diabetic and diabetic cerebral ischemic-reperfused rats showed significant reduction in body weight, hyperglycemia, increased glycated hemoglobin %, and a change in lipid profile characterized by elevated serum cholesterol, LDL, triglycerides levels and increased atherogenic indices while serum HDL remains unchanged. These groups showed increased formation of lipid peroxides (MDA) and depletion of internal antioxidant GSH in brain tissues. I/R injury increased infarction areas, serum NO level, and inflammatory marker; serum ICAM-1 levels and up-regulated brain iNOS expression in diabetic animals. Moreover, increased brain expressions of apoptotic P53 and antiapoptotic Bcl-2 proteins were noted. Finally, I/R injury was confirmed by brain histopathological changes. Statins treatment was not able to change blood glucose level or lipid profile, but they provided protection against cerebral I/R injury as indicated by reduced oxidative stress, decline in inflammatory markers and infarction areas. Statins reduced ICAM-1 and induced down regulations of p53 and Bcl-2 and iNOS expression. The results of this research suggest that enhanced cerebral apoptosis is critically involved in cerebral damage associated with diabetes and cerebral ischemic-reperfusion. These results suggested that statins may represent a new approach for treating cerebrovascular diseases. Further clinical evidence is needed to support these observations.
Biography

Email: hananhhagar@yahoo.com

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top